In conclusion, our findings indicate that promoter hypomethylation of the PDZK1 promoter was the reason for the high expression of PDZK1 in glioma, and the methylation level of PDZK1 is a meaningful prognostic marker in glioma. The gene discussed is PDZK1; the disease is central nervous system cancer.